Recent News
On January 30, 2026 the board declared a quarterly cash dividend of $0.08 per share payable March 2, 2026, to holders of record as of February 13, 2026, and authorized a $10.0 million share repurchase program effective March 1, 2026. On January 5, 2026 the company extended its registered exchange offer for up to $100.0 million of 7.25% fixed-to-floating subordinated notes, moving the deadline to January 9, 2026. During early February 2026 the stock reached a new 52‑week high and several brokers revised ratings and targets upward while noting the company’s capital-return actions. In late November 2025 consensus coverage aggregated to a hold/neutral posture among a small set of analysts.
Technical Analysis
ADX at 30.44 indicates a strong trend environment; trend strength amplifies directional signals when they align with momentum. The directional indicators point toward bearish directionality: DI+ at 30.74 shows a peak & reversal, and DI- at 16.68 shows a dip & reversal, which together reflect directional pressure toward sellers despite the underlying trend strength.
MACD sits at 0.93 with the MACD signal at 0.93 and a MACD trend labeled peak & reversal; that configuration and the peak reversal indicate a shift to bearish momentum despite a still-positive absolute MACD reading.
MRO at 5.95 (positive) signals price sits modestly above the model target and therefore carries a higher probability of near-term downward pressure; the MRO trend registers a peak & reversal, reinforcing pullback risk from current levels.
RSI at 58.86 with a peak & reversal profile shows recent relative-strength exhaustion without reaching overbought extremes, increasing the probability of consolidation or a modest decline rather than a sustained breakout.
Price relationships favor a short-term above‑average bias but with signs of topping: last close $41.47 trades marginally above the 20‑day average $41.45 and above the 50‑day $39.23 and 200‑day $35.61, while the 12‑day EMA shows a peak & reversal. Price sits inside the 1x Bollinger band range ($39.93–$42.98) near the upper half, and the SuperTrend lower level at $40.59 lies below the close, offering a mechanical reference for near-term support. Low relative volume—today’s 37,751 versus a 10‑day average of 78,955—suggests recent moves occur with lighter participation, reducing conviction behind the advance.
Fundamental Analysis
Reported EPS of $0.81 beat the $0.78 estimate by $0.03, a 3.85% EPS surprise. Operating metrics show strains: earnings growth reads -5.81% on the headline measure, quarterly change at -123.60%, and year‑over‑year growth per the supplied field at -204.64% (all values shown as percentages per the provided data). Revenue growth shows a decline of -4.32% overall with the provided year-over-year figure at -172.30% as reported in the dataset.
P/E stands at 45.82x compared with an industry peer mean of 49.56x; the multiple sits below the industry peer mean and inside the industry peer range but above the industry peer median, indicating relative valuation slightly compressed versus the peer mean while still elevated in absolute terms. Forward P/E of 37.29x reflects expected earnings progression to forward EPS $1.02. PEG registers at -7.88 versus an industry peer mean of 0.57, placing the stock materially below the peer mean on the PEG metric given negative or non-linear growth inputs.
Cash-flow-to-earnings shows 0.0% in the provided fields; invested capital registers as a negative $427,841,000. Cost of debt stands at 28.37%, reflecting the stated cost inputs. Forward EPS at $1.0155 and a forward P/E of 37.29x suggest the market prices future earnings improvement into the multiple. Price target mean at $40.83 sits slightly below the last close $41.47, with the analyst target range from $27.91 to $61.13.
WMDST values the stock as over‑valued based on the current multiple structure, forward estimates, and the capital-return actions now priced into a relatively tight trading range.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-01-20 |
| NEXT REPORT DATE: | 2026-04-21 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 0.78 | |
| EPS Actual | $ 0.81 | |
| EPS Difference | $ 0.03 | |
| EPS Surprise | 3.846 % | |
| Forward EPS | $ 1.02 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 45.818 | |
| Price To Earnings QoQ | 11.808 % | |
| Price To Earnings YoY | -18.405 % | |
| Price To Earnings IPRWA | high: 73.773 mean: 49.561 SMBK: 45.818 median: 31.733 low: 30.108 |
|
| PE/G Ratio | -7.881 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 37.288 | |
| Forward PE/G | -6.414 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -427.84 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 28.369 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | -4.324 % | |
| Revenue Growth QoQ | -0.0 % | |
| Revenue Growth YoY | -172.296 % | |
| Revenue Growth IPRWA | high: 23.369 % mean: 4.324 % median: -3.782 % SMBK: -4.324 % low: -9.053 % |
|
| Earnings Growth | -5.814 % | |
| Earnings Growth QoQ | -123.598 % | |
| Earnings Growth YoY | -204.644 % | |
| Earnings Growth IPRWA | high: 44.444 % mean: 2.126 % SMBK: -5.814 % median: -21.818 % low: -25.0 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |